Vitamin B3 may offer new tool in fight against 'superbugs'

August 27, 2012

A new study suggests that nicotinamide, more commonly known as vitamin B3, may be able to combat some of the antibiotic-resistance staph infections that are increasingly common around the world, have killed thousands and can pose a significant threat to public health.

The research found that high doses of this vitamin increased by 1,000 times the ability of immune cells to kill . The work was done both in laboratory animals and with human blood.

The findings were published today in the by researchers from Cedars-Sinai Medical Center, the Linus Pauling Institute at Oregon State University, UCLA, and other institutions. The research was supported by several grants from the National Institutes of Health.

The work may offer a new avenue of attack against the growing number of "superbugs."

"This is potentially very significant, although we still need to do human studies," said Adrian Gombart, an associate professor in OSU's Linus Pauling Institute. "Antibiotics are wonder drugs, but they face increasing problems with resistance by various types of bacteria, especially .

"This could give us a new way to treat staph infections that can be deadly, and might be used in combination with current antibiotics," Gombart said. "It's a way to tap into the power of the and stimulate it to provide a more powerful and natural immune response."

The scientists found that clinical doses of nicotinamide increased the numbers and efficacy of "neutrophils," a specialized type of white blood cell that can kill and eat .

The nicotinamide was given at megadose, or therapeutic levels, far beyond what any normal diet would provide - but nonetheless in amounts that have already been used safely in humans, as a drug, for other medical purposes.

However, there is no evidence yet that normal diets or conventional-strength supplements of vitamin B3 would have any beneficial effect in preventing or treating bacterial infection, Gombart said, and people should not start taking high doses of the vitamin.

Gombart has been studying some of these issues for more than a decade, and discovered 10 years ago a human genetic mutation that makes people more vulnerable to bacterial infections. In continued work on the genetic underpinnings of this problem, researchers found that nicotinamide had the ability to "turn on" certain antimicrobial genes that greatly increase the ability of to kill bacteria.

One of the most common and serious of the staph infections, called methicillin-resistant S. aureus, or MRSA, was part of this study. It can cause serious and life-threatening illness, and researchers say the widespread use of antibiotics has helped increase the emergence and spread of this bacterial pathogen.

Dr. George Liu, an infectious disease expert at Cedars-Sinai and co-senior author on the study, said that "this vitamin is surprisingly effective in fighting off and protecting against one of today's most concerning public health threats." Such approaches could help reduce dependence on antibiotics, he said.

Co-first authors Pierre Kyme and Nils Thoennissen found that when used in human blood, clinical doses of appeared to wipe out the staph infection in only a few hours.

Serious , such as those caused by MRSA, are increasingly prevalent in hospitals and nursing homes, but are also on the rise in prisons, the military, among athletes, and in other settings where many people come into close contact.

Explore further: Researchers closer to the super bug puzzle

Related Stories

Researchers closer to the super bug puzzle

November 11, 2011
Infectious diseases specialists from Austin Health are working closely with Microbiologists from the University of Melbourne to understand how Staph is becoming resistant to all antibiotic therapies.

Like curry? New biological role identified for compound used in ancient medicine

May 25, 2012
Scientists have just identified a new reason why some curry dishes, made with spices humans have used for thousands of years, might be good for you.

Recommended for you

Researchers identify possible biomarker for diagnosing chronic traumatic encephalopathy during life

September 26, 2017
A new biomarker (CCL11) for chronic traumatic encephalopathy (CTE) has been discovered that may allow the disease to be diagnosed during life for the first time.

Lactation hormone also helps a mother's brain

September 26, 2017
The same hormone that stimulates milk production for lactation, also acts in the brain to help establish the nurturing link between mother and baby, University of Otago researchers have revealed for the first time.

Image ordering often based on factors other than patient need: study

September 25, 2017
Do you really need that MRI?

Bone marrow concentrate improves joint transplants

September 25, 2017
Biologic joint restoration using donor tissue instead of traditional metal and plastic may be an option for active patients with joint defects. Although recovery from a biologic joint repair is typically longer than traditional ...

Researchers describe mechanism that underlies age-associated bone loss

September 22, 2017
A major health problem in older people is age-associated osteoporosis—the thinning of bone and the loss of bone density that increases the risk of fractures. Often this is accompanied by an increase in fat cells in the ...

Researchers develop treatment to reduce rate of cleft palate relapse complication

September 22, 2017
Young people with cleft palate may one day face fewer painful surgeries and spend less time undergoing uncomfortable orthodontic treatments thanks to a new therapy developed by researchers from the UCLA School of Dentistry. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.